Is Agios Pharmaceuticals a buy?
Is Agios Pharmaceuticals a buy?
Agios Pharmaceuticals has received a consensus rating of Hold. The company’s average rating score is 2.44, and is based on 5 buy ratings, 3 hold ratings, and 1 sell rating.
What happened to Agios Pharmaceuticals?
Agios Pharmaceuticals (AGIO) Reports Q4 Loss, Lags Revenue Estimates. Agios Pharmaceuticals (AGIO) delivered earnings and revenue surprises of -5.85% and 100%, respectively, for the quarter ended December 2021.
When did Agios Pharmaceuticals go public?
–(BUSINESS WIRE)–Jul. 23, 2013– Agios Pharmaceuticals, Inc. today announced the pricing of its initial public offering of 5,888,888 shares of its common stock at a public offering price of $18.00 per share, before underwriting discounts.
What industry is Agios Pharmaceuticals?
biopharmaceutical company
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology.
Is Agios a good company?
Is Agios Pharmaceuticals a good company to work for? Agios Pharmaceuticals has an overall rating of 4.2 out of 5, based on over 86 reviews left anonymously by employees. 79% of employees would recommend working at Agios Pharmaceuticals to a friend and 60% have a positive outlook for the business.
What does Agios mean in English?
Agios (Greek: Άγιος), plural Agioi (Άγιοι), transcribes masculine gender Greek words meaning ‘sacred’ or ‘saint’ (for example Agios Dimitrios, Agioi Anargyroi). It is frequently shortened in colloquial language to Ai (for example Ai Stratis).
What does Agios mean in French?
exorbitant (exorbitante) prix, agios. exorbitant.
How much of Agios Pharmaceuticals stock are insiders buying or selling?
In the past three months, Agios Pharmaceuticals insiders have sold more of their company’s stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $22,929.00 in company stock. Only 3.16% of the stock of Agios Pharmaceuticals is held by insiders.
Where is Agios Pharmaceuticals located?
Agios Pharmaceuticals is headquartered at 88 SIDNEY STREET, CAMBRIDGE MA, 02139. How can I contact Agios Pharmaceuticals? Agios Pharmaceuticals’ mailing address is 88 SIDNEY STREET, CAMBRIDGE MA, 02139. The biopharmaceutical company can be reached via phone at (617) 649-8600 or via email at [email protected].
What is Agios therapeutics’clinical development strategy?
The company’s primary focus is to develop potentially transformative small-molecule medicines. The clinical development strategy for Agios’ product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations.
https://www.youtube.com/watch?v=317nw0fhES4